HERNANDEZ JOSEPH (Chief Executive Officer) received a stock award from CLARUS THERAPEUTICS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/9/2022ACC: 0000899243-22-021755
DirectorOfficer10% Owner· Chief Executive Officer
Since Dec 2020
+6.73K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
6.73K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.92K
Price / share
—
Trade value
—
% of position
0.2%
6/7/2022
1.24M→1.24M
Total
Net shares
+1.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/7/2022 | A · Award | +1.92K | — | — | 0.2% | 1.24M | 1.24M |
| Total | +1.92K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
4.80K shares
Shares
+4.80K
Strike price
0.4339
Held after
4.80K
Exercisable
—
6/7/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock4.80K shares | 6/7/2022 | A · Award | +4.80K | 0.4339 | — | 4.80K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned65K
Total
65K indirect65K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 65K | Indirect |
| Total | 65K | 65K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported